WR1 General Discussion, page-30550

That certainly seems to be the case. For a short while after early February there was a little optimism that we might get back to a healthier spodumene price this year but it doesn't seem to be happening. So it's hardly surprising that the less-committed holders in these stocks are selling out and that new buyers are holding back for even lower entries. At $2,000/t I should think we'd be sitting up at a record high now. Our best hope is that even at the current low spod price our PEA will indicate the project still being sufficiently viable to both proceed and entice investors to see value down at this low MC. If the Renard plant forms part of the preferred scenario and is acquired at least we should be streets ahead of so many other small fish who will really struggle to develop if a depressed market perseveres.